HK1215792A1 - Bakuchiol compositions for treatment of post inflammatory hyperpigmentation - Google Patents
Bakuchiol compositions for treatment of post inflammatory hyperpigmentationInfo
- Publication number
- HK1215792A1 HK1215792A1 HK16103749.0A HK16103749A HK1215792A1 HK 1215792 A1 HK1215792 A1 HK 1215792A1 HK 16103749 A HK16103749 A HK 16103749A HK 1215792 A1 HK1215792 A1 HK 1215792A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- inflammatory hyperpigmentation
- post inflammatory
- bakuchiol compositions
- bakuchiol
- Prior art date
Links
- LFYJSSARVMHQJB-UHFFFAOYSA-N Backuchiol Natural products CC(C)=CCCC(C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-UHFFFAOYSA-N 0.000 title 1
- 206010036229 Post inflammatory pigmentation change Diseases 0.000 title 1
- LFYJSSARVMHQJB-GOSISDBHSA-N bakuchinol Natural products CC(C)=CCC[C@@](C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-GOSISDBHSA-N 0.000 title 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 title 1
- 229940117895 bakuchiol Drugs 0.000 title 1
- KXXXNMZPAJTCQY-UHFFFAOYSA-N bakuchiol Natural products CC(C)CCCC(C)(C=C)C=Cc1ccc(O)cc1 KXXXNMZPAJTCQY-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161438890P | 2011-02-02 | 2011-02-02 | |
| PCT/US2011/026594 WO2012105990A1 (en) | 2011-02-02 | 2011-03-01 | Bakuchiol compositions for treatment of post inflammatory hyperpigmentation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1215792A1 true HK1215792A1 (en) | 2016-09-15 |
Family
ID=46603028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16103749.0A HK1215792A1 (en) | 2011-02-02 | 2016-04-01 | Bakuchiol compositions for treatment of post inflammatory hyperpigmentation |
Country Status (8)
| Country | Link |
|---|---|
| KR (5) | KR101954118B1 (en) |
| CN (2) | CN105147533B (en) |
| AU (1) | AU2012212153B9 (en) |
| BR (1) | BR112013019798A2 (en) |
| CA (4) | CA3128715A1 (en) |
| HK (1) | HK1215792A1 (en) |
| MX (1) | MX350719B (en) |
| WO (1) | WO2012105990A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10471035B2 (en) | 2014-10-20 | 2019-11-12 | Sunny BioDiscovery | Compositions and methods for using esters of meroterpenes and of other resveratrol analogues |
| CN105675741A (en) * | 2015-12-30 | 2016-06-15 | 成都九芝堂金鼎药业有限公司 | Method for determining content of effective components in hair growing pill |
| KR20190116858A (en) | 2018-04-05 | 2019-10-15 | 주식회사 엑소코바이오 | A composition comprising an exosome and/or extracellular vesicle derived from stem cell as an active ingredient and its application for preventing, alleviating, reducing or removing postinflammatory hyperpigmentation |
| CN111544317B (en) * | 2020-04-29 | 2022-01-14 | 珀莱雅化妆品股份有限公司 | Anti-aging composition cationic nano-liposome and preparation method and application thereof |
| CN114478196B (en) * | 2021-01-27 | 2023-11-10 | 江苏巴帝恩生物科技有限公司 | Method for extracting and purifying bakuchiol from Ulmus pumila root and application of bakuchiol in cosmetics |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2617473B2 (en) | 1987-06-30 | 1997-06-04 | キヤノン株式会社 | Information input device |
| BRPI0608796B8 (en) * | 2005-05-09 | 2021-05-25 | Unigen Pharmaceuticals Inc | method for preparing a plant extract comprising bacuquiol |
| WO2008140673A1 (en) * | 2007-05-14 | 2008-11-20 | Sytheon Ltd. | Skin treatment compositions and methods |
-
2011
- 2011-03-01 WO PCT/US2011/026594 patent/WO2012105990A1/en active Application Filing
-
2012
- 2012-02-02 BR BR112013019798A patent/BR112013019798A2/en not_active Application Discontinuation
- 2012-02-02 MX MX2013008890A patent/MX350719B/en active IP Right Grant
- 2012-02-02 CA CA3128715A patent/CA3128715A1/en active Pending
- 2012-02-02 KR KR1020137022953A patent/KR101954118B1/en active IP Right Grant
- 2012-02-02 CA CA2826262A patent/CA2826262C/en active Active
- 2012-02-02 AU AU2012212153A patent/AU2012212153B9/en active Active
- 2012-02-02 KR KR1020237013482A patent/KR102642352B1/en active IP Right Grant
- 2012-02-02 CN CN201510390680.7A patent/CN105147533B/en active Active
- 2012-02-02 CA CA3128718A patent/CA3128718A1/en active Pending
- 2012-02-02 KR KR1020207026173A patent/KR102333655B1/en active IP Right Grant
- 2012-02-02 KR KR1020217038833A patent/KR102525516B1/en active IP Right Grant
- 2012-02-02 CA CA3128711A patent/CA3128711A1/en active Pending
- 2012-02-02 CN CN201280015007.XA patent/CN103458882B/en active Active
- 2012-02-02 KR KR1020197005663A patent/KR102156731B1/en active IP Right Grant
-
2016
- 2016-04-01 HK HK16103749.0A patent/HK1215792A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2826262A1 (en) | 2012-08-09 |
| CN103458882A (en) | 2013-12-18 |
| MX350719B (en) | 2017-09-14 |
| CA3128718A1 (en) | 2012-08-09 |
| KR102156731B1 (en) | 2020-09-16 |
| CA2826262C (en) | 2021-10-26 |
| MX2013008890A (en) | 2013-10-17 |
| KR102642352B1 (en) | 2024-02-28 |
| CA3128711A1 (en) | 2012-08-09 |
| KR20200108120A (en) | 2020-09-16 |
| AU2012212153B2 (en) | 2017-04-06 |
| KR20190025740A (en) | 2019-03-11 |
| CN105147533A (en) | 2015-12-16 |
| AU2012212153B9 (en) | 2017-05-11 |
| AU2012212153A1 (en) | 2013-08-29 |
| BR112013019798A2 (en) | 2017-07-04 |
| KR20210145864A (en) | 2021-12-02 |
| WO2012105990A1 (en) | 2012-08-09 |
| CN105147533B (en) | 2018-07-31 |
| KR102333655B1 (en) | 2021-12-01 |
| CN103458882B (en) | 2015-08-05 |
| KR102525516B1 (en) | 2023-04-24 |
| CA3128715A1 (en) | 2012-08-09 |
| KR20140008364A (en) | 2014-01-21 |
| KR20230058727A (en) | 2023-05-03 |
| KR101954118B1 (en) | 2019-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2717926A4 (en) | Compositions and methods to prevent and treat biofilms | |
| EP2712362A4 (en) | Manufacture of lacto-n-tetraose | |
| IL229830B (en) | Novel compinds as modulatord of gpr-119 | |
| EP2723384A4 (en) | Treatment of proteinopathies | |
| EP2554175A4 (en) | Composition for treatment of damaged part | |
| EP2771030A4 (en) | Compositions and methods for treatment of proteinopathies | |
| EP2766390A4 (en) | Compositions and methods for treating heart failure | |
| HK1190936A1 (en) | Methods and compositions for treating metabolic syndrome | |
| HK1199015A1 (en) | Treatment of inflammation | |
| ZA201404482B (en) | Seed treatment composition | |
| IL228630A0 (en) | Compounds for treatment of metabolic syndrome | |
| HRP20180567T1 (en) | Pharmaceutical composition of omeprazole | |
| HK1215792A1 (en) | Bakuchiol compositions for treatment of post inflammatory hyperpigmentation | |
| IL231622B (en) | Pharmaceutical composition for treatment of cachexia | |
| PT2739276T (en) | Antiseptic composition | |
| EP2763756A4 (en) | Bromofluorocarbon compositions | |
| EP2727586A4 (en) | Soyasapogenol composition | |
| EP2768481A4 (en) | Compositions for reduction of side effects | |
| ZA201401847B (en) | Cleansing composition | |
| HK1177432A1 (en) | Composition for amelioration of hypoalbuminemia | |
| EP2718427A4 (en) | Compositions and methods for glioblastoma treatment | |
| HK1199818A1 (en) | Treatment of seborrhoea | |
| GB201115652D0 (en) | Water stable form of glutamine | |
| IL213610A0 (en) | Composition for treating dermatological conditions | |
| GB201100651D0 (en) | Treatment of inflammation |